Showing results (1741-1750 of 1,802) with videos related to

Sort By:
Pageof 181
Epilepsia|September 22, 2000
Prospective long-term study of vagus nerve stimulation for the treatment of refractory seizuresC M DeGiorgio, S C Schachter, A Handforth, et al.
Journal of Skin Cancer|February 1, 2013
Safety and efficacy of 188-rhenium-labeled antibody to melanin in patients with metastatic melanomaM Klein, M Lotem, T Peretz, et al.
Blood|April 19, 2022
Impact of CD19 CAR T-cell product type on outcomes in relapsed or refractory aggressive B-NHLJordan Gauthier, Nicolas Gazeau, Alexandre V Hirayama, et al.
The Journal of Pharmacology and Experimental Therapeutics|August 22, 2006
Concentration-dependent modulation of amyloid-beta in vivo and in vitro using the gamma-secretase inhibitor, LY-450139Thomas A Lanz, Michael J Karmilowicz, Kathleen M Wood, et al.
Journal of Medicinal Chemistry|September 6, 2019
Discovery of MK-8719, a Potent O-GlcNAcase Inhibitor as a Potential Treatment for TauopathiesHarold G Selnick, J Fred Hess, Cuyue Tang, et al.
Cancer Research|August 15, 2008
Inhibition of the sodium/potassium ATPase impairs N-glycan expression and functionReza Beheshti Zavareh, Ken S Lau, Rose Hurren, et al.
European Journal of Cancer (Oxford, England : 1990)|December 24, 2018
An open-label, multicentre safety study of vemurafenib in patients with BRAFV600-mutant metastatic melanoma: final analysis and a validated prognostic scoring systemJames Larkin, Michael P Brown, Ana M Arance, et al.
Epilepsy & Behavior : E&B|August 16, 2015
Third International Congress on Epilepsy, Brain and Mind: Part 1Amos D Korczyn, Steven C Schachter, Jana Amlerova, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 10, 2021
Role of Tumor-Infiltrating B Cells in Clinical Outcome of Patients with Melanoma Treated With Dabrafenib Plus TrametinibJan C Brase, Robert F H Walter, Alexander Savchenko, et al.
IEEE Journal of Translational Engineering in Health and Medicine|October 13, 2016
National Institute of Biomedical Imaging and Bioengineering Point-of-Care Technology Research Network: Advancing Precision MedicinePenny Ford Carleton, Steven Schachter, John A Parrish, et al.
Pageof 181